文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

基于天然细胞的仿生细胞转化器用于消化系统癌症的靶向治疗。

Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer.

机构信息

Department of Pharmacy, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, China.

出版信息

Theranostics. 2022 Oct 9;12(16):7080-7107. doi: 10.7150/thno.75937. eCollection 2022.


DOI:10.7150/thno.75937
PMID:36276645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9576611/
Abstract

Digestive system cancer is the most common cause of cancer death in the world. Although cancer treatment options are increasingly diversified, the mortality rate of malignant cancer of the digestive system remains high. Therefore, it is necessary to explore effective cancer treatment methods. Recently, biomimetic nanoparticle delivery systems based on natural cells that organically integrate the low immunogenicity, high biocompatibility, cancer targeting, and controllable, versatile functionality of smart nanocarrier design with natural cells have been expected to break through the bottleneck of tumor targeted therapy. In this review, we focus on the dynamic changes and complex cellular communications that occur in natural cells based vehicles. Recent studies on the development of advanced targeted drug delivery systems using the dynamic behaviors such as specific surface protein affinity, morphological changes, and phenotypic polarization of natural cells are summarized. In addition to drug delivery mediated by dynamic behavior, functional "delivery" based on the natural cell themselves is also involved. Aiming to make the best use of the functions of cells, providing clues for the development of advanced drug delivery platforms.

摘要

消化系统癌症是全球癌症死亡的最常见原因。尽管癌症治疗选择日益多样化,但消化系统恶性癌症的死亡率仍然很高。因此,有必要探索有效的癌症治疗方法。最近,基于天然细胞的仿生纳米颗粒递药系统,将智能纳米载体设计的低免疫原性、高生物相容性、癌症靶向和可控、多功能性与天然细胞的有机整合,有望突破肿瘤靶向治疗的瓶颈。在本综述中,我们重点关注天然细胞载体中发生的动态变化和复杂的细胞间通讯。总结了利用天然细胞的特异性表面蛋白亲和力、形态变化和表型极化等动态行为开发先进靶向药物递药系统的最新研究进展。除了通过动态行为介导的药物递药,还涉及基于天然细胞本身的功能“递药”。旨在充分利用细胞的功能,为开发先进的药物递药平台提供线索。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/527b9ac4dfd2/thnov12p7080g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/67a1fc8c0c92/thnov12p7080g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/874bd4666561/thnov12p7080g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/ef22438ab446/thnov12p7080g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/6c819ab55cf3/thnov12p7080g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/a70dfc5681a7/thnov12p7080g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/78b4eb7eeddf/thnov12p7080g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/71e8d8979fd6/thnov12p7080g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/45cab66d3e2e/thnov12p7080g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/2befca953817/thnov12p7080g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/153696667ac9/thnov12p7080g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/527b9ac4dfd2/thnov12p7080g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/67a1fc8c0c92/thnov12p7080g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/874bd4666561/thnov12p7080g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/ef22438ab446/thnov12p7080g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/6c819ab55cf3/thnov12p7080g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/a70dfc5681a7/thnov12p7080g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/78b4eb7eeddf/thnov12p7080g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/71e8d8979fd6/thnov12p7080g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/45cab66d3e2e/thnov12p7080g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/2befca953817/thnov12p7080g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/153696667ac9/thnov12p7080g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d33/9576611/527b9ac4dfd2/thnov12p7080g011.jpg

相似文献

[1]
Natural cell based biomimetic cellular transformers for targeted therapy of digestive system cancer.

Theranostics. 2022

[2]
Advances in Biomimetic Nanoparticles for Targeted Cancer Therapy and Diagnosis.

Molecules. 2021-8-20

[3]
Bioinspired and biomimetic systems for advanced drug and gene delivery.

J Control Release. 2018-8-28

[4]
Biomimetic Nano-Drug Delivery System: An Emerging Platform for Promoting Tumor Treatment.

Int J Nanomedicine. 2024

[5]
Application of Biomimetic Nanoparticles based on the Cell Membrane in Tumor Therapy.

Curr Top Med Chem. 2023

[6]
Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.

Drug Deliv. 2021-12

[7]
Biomimetic nanoarchitecturing: A disguised attack on cancer cells.

J Control Release. 2021-1-10

[8]
Red blood cells based nanotheranostics: A smart biomimetic approach for fighting against cancer.

Int J Pharm. 2024-8-15

[9]
Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.

Acta Biomater. 2020-8

[10]
Engineering carrier nanoparticles with biomimetic moieties for improved intracellular targeted delivery of mRNA therapeutics and vaccines.

J Pharm Pharmacol. 2024-6-6

引用本文的文献

[1]
Research progress on m6A and drug resistance in gastrointestinal tumors.

Front Pharmacol. 2025-4-28

[2]
Neutrophil diversity and function in health and disease.

Signal Transduct Target Ther. 2024-12-6

[3]
Biomimetic nanocarriers in cancer therapy: based on intercellular and cell-tumor microenvironment communication.

J Nanobiotechnology. 2024-10-6

[4]
Deep learning enhanced the diagnostic merit of serum glycome for multiple cancers.

iScience. 2023-12-13

[5]
Cell-membrane-coated nanoparticles for the fight against pathogenic bacteria, toxins, and inflammatory cytokines associated with sepsis.

Theranostics. 2023

本文引用的文献

[1]
Brain co-delivery of first-line chemotherapy drug and epigenetic bromodomain inhibitor for multidimensional enhanced synergistic glioblastoma therapy.

Exploration (Beijing). 2022-4-19

[2]
Engineered cancer cell membranes: An emerging agent for efficient cancer theranostics.

Exploration (Beijing). 2022-1-25

[3]
Stem cell membrane-coated abiotic nanomaterials for biomedical applications.

J Control Release. 2022-11

[4]
Stem cell membrane-camouflaged targeted delivery system in tumor.

Mater Today Bio. 2022-8-1

[5]
Membrane-camouflaged supramolecular nanoparticles for co-delivery of chemotherapeutic and molecular-targeted drugs with siRNA against patient-derived pancreatic carcinoma.

Acta Pharm Sin B. 2022-8

[6]
Nanoparticle functionalization with genetically-engineered mesenchymal stem cell membrane for targeted drug delivery and enhanced cartilage protection.

Biomater Adv. 2022-5

[7]
Optimization of Biomimetic, Leukocyte-Mimicking Nanovesicles for Drug Delivery Against Colorectal Cancer Using a Design of Experiment Approach.

Front Bioeng Biotechnol. 2022-6-8

[8]
Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy.

Adv Mater. 2022-8

[9]
Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.

J Control Release. 2022-8

[10]
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.

Sci Immunol. 2022-6-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索